Twist Bioscience Corporation (TWST) Operating margin 2017–2025
Twist Bioscience Corporation (TWST) operating margin by fiscal year — reported operating income divided by reported revenue.
-36.2%FY2025 · since FY2017: -543.2% → -36.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -36.2% | +34.4 pp |
| FY2024 | -70.6% | +18.0 pp |
| FY2023 | -88.6% | +26.7 pp |
| FY2022 | -115.3% | +0.1 pp |
| FY2021 | -115.4% | +40.1 pp |
| FY2020 | -155.5% | +44.7 pp |
| FY2019 | -200.1% | +77.3 pp |
| FY2018 | -277.5% | +265.7 pp |
| FY2017 | -543.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice